[ad_1] Eli Lilly started a new online service offering telehealth prescriptions and direct home delivery of its new anti-obesity drug Zepbound, an unusual move into the drug supply chain by…
Tag: wsjhealth
Minnesota Nice Wants Minnesota Ice: Locals Crave Bone-Chilling Normal
[ad_1] ‘Maybe we’ll get lucky and have a polar vortex.’ Milder weather is shaking up routines, though golfing in winter isn’t too bad. [ad_2] Source link
Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion
[ad_1] Updated Dec. 26, 2023 12:33 pm ET Drug company Bristol-Myers Squibb struck a $4.1 billion deal to buy RayzeBio, in a bet on a re-emerging cancer drug technology. RayzeBio…
Illumina to Divest Itself of Cancer-Test Maker Grail
[ad_1] Updated Dec. 17, 2023 8:16 pm ET Gene-sequencing company Illumina said Sunday it will divest itself of cancer blood test maker Grail, following Illumina’s loss in its legal battle…
How to Make the Most of Your FSA Money Before It Disappears
[ad_1] The flexible-spending account, or FSA, is one of two common ways of paying for healthcare expenses tax-free. With an FSA, employees can deduct a certain amount of money from…
Matthew Perry Died From Effects of Ketamine, Autopsy Shows
[ad_1] Updated Dec. 15, 2023 7:18 pm ET Matthew Perry died from the acute effects of ketamine, according to an autopsy of the “Friends” actor released Friday. The 54-year-old actor,…
The Hormone That Could Lead to a Cure for Morning Sickness
[ad_1] Updated Dec. 13, 2023 12:02 pm ET Pregnant and nauseous? Blame your baby. A hormone that triggers nausea and vomiting is produced abundantly by the fetal portion of the…
The Forgotten Man of mRNA Research
[ad_1] Jason Schrum’s work helped lay the foundation for Moderna’s mRNA Covid vaccine, but he hasn’t won any prizes or royalties and left the company after disagreements. [ad_2] Source link
Pfizer Warns 2024 Revenue Could Fall, Weighed Down by Soft Demand for Covid Products
[ad_1] Updated Dec. 13, 2023 10:16 am ET Pfizer shares tumbled Wednesday morning after the company said revenue could fall next year and issued 2024 guidance below analyst expectations. Shares…